ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F21%3A10430099" target="_blank" >RIV/00216208:11110/21:10430099 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/21:10430099

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7AdNmCuI19" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7AdNmCuI19</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1097/MAT.0000000000001510" target="_blank" >10.1097/MAT.0000000000001510</a>

Jazyk výsledku

angličtina

Název v původním jazyce

ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients

Popis výsledku v původním jazyce

Over the past decade, the use of extracorporeal membrane oxygenation (ECMO) has increased exponentially, from approximately 30-40 patients per year in the United States 20 years ago, to over 2,000 per year currently, and rising. The increased utilization of ECMO has resulted from improved cannulation techniques, including percutaneous approach, as well as advances in the technology of the pumps, oxygenators, and cannulas. Despite these features, however, choosing appropriate candidates and managing their daily care can be extremely challenging. What follows is an in-depth discussion of the indications for venoarterial (VA) ECMO in adult patients affected by cardiac disease, the manner of its application, the physiology underlying the care for these patients, and the assessment and treatment of complications, including ethical and organizational issues. More in-depth material and information are provided in the Extracorporeal Life Support Organization (ELSO) 5th Edition Red Book. Furthermore, the recent ELSO indications about ECLS and cannulation nomenclature will be followed in this guideline.

Název v anglickém jazyce

ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients

Popis výsledku anglicky

Over the past decade, the use of extracorporeal membrane oxygenation (ECMO) has increased exponentially, from approximately 30-40 patients per year in the United States 20 years ago, to over 2,000 per year currently, and rising. The increased utilization of ECMO has resulted from improved cannulation techniques, including percutaneous approach, as well as advances in the technology of the pumps, oxygenators, and cannulas. Despite these features, however, choosing appropriate candidates and managing their daily care can be extremely challenging. What follows is an in-depth discussion of the indications for venoarterial (VA) ECMO in adult patients affected by cardiac disease, the manner of its application, the physiology underlying the care for these patients, and the assessment and treatment of complications, including ethical and organizational issues. More in-depth material and information are provided in the Extracorporeal Life Support Organization (ELSO) 5th Edition Red Book. Furthermore, the recent ELSO indications about ECLS and cannulation nomenclature will be followed in this guideline.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

ASAIO Journal

ISSN

1058-2916

e-ISSN

—

Svazek periodika

67

Číslo periodika v rámci svazku

8

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

18

Strana od-do

827-844

Kód UT WoS článku

000680139500009

EID výsledku v databázi Scopus

2-s2.0-85112653843